|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-19
|
|
pubmed:abstractText |
Invasive fungal infections are becoming increasingly prevalent and are more frequently the aetiological agents responsible for nosocomial infections. Since mid-2002, two new antifungal drugs - voriconazole, a third-generation azole, and caspofungin, a member of a new class of drugs called echinocandins - have been marketed in Spain. Both drugs have proven [corrected] efficacy in the treatment of aspergillosis, are better tolerated than amphotericin B and are cheaper [corrected] than liposomal amphotericin B. The objective of this study was to conduct an economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1173-2563
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
197-205
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17305414-Administration, Oral,
pubmed-meshheading:17305414-Antifungal Agents,
pubmed-meshheading:17305414-Aspergillosis,
pubmed-meshheading:17305414-Body Weight,
pubmed-meshheading:17305414-Cost-Benefit Analysis,
pubmed-meshheading:17305414-Echinocandins,
pubmed-meshheading:17305414-Health Care Costs,
pubmed-meshheading:17305414-Humans,
pubmed-meshheading:17305414-Injections, Intravenous,
pubmed-meshheading:17305414-Multivariate Analysis,
pubmed-meshheading:17305414-Peptides, Cyclic,
pubmed-meshheading:17305414-Pyrimidines,
pubmed-meshheading:17305414-Severity of Illness Index,
pubmed-meshheading:17305414-Spain,
pubmed-meshheading:17305414-Treatment Outcome,
pubmed-meshheading:17305414-Triazoles
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
|
|
pubmed:affiliation |
Servicio de Farmacia, Hospital Universitario de Salamanca, Salamanca, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
